After including SHH expression level in the multivariate model above, SHH expression level remained significant and even increased the significance of SMO expression level. After adjusting for age, sex, and histological type, increase in SMO expression level strongly correlates with #LGX818 mw randurls[1|1|,|CHEM1|]# increase in risk of death (95% CI, 8-72%; p = 0.009; data not shown); and so does increase

in SHH expression level (95% CI, 1-26%; p = 0.04; data not shown). Histological type was no longer associated with overall survival (p = 0.87). SMO Inhibition suppresses mesothelioma cell proliferation To assess the role of Hh signaling in tumor growth of mesothelioma, we utilized a small molecule Hh signaling inhibitor cyclopamine which specifically antagonizes SMO receptor [11]. Three mesothelioma cell lines were treated with cyclopamine and examined for expression of several key Tucidinostat clinical trial effectors of the SHH pathway. Expression of all Gli downstream effector genes (including GLI1, GLI2, PTCH, PTCH2) was suppressed, suggesting the specificity of cyclopamine in inhibiting the SHH pathway (Figure 4). Figure 4 Quantitative RT-PCR analysis of Shh pathway effectors in mesothelioma cell lines treated with cyclopamine. Cells were treated with 15 uM cyclopamine for 72 hrs. RNA was then collected for cDNA

synthesis and quantitative PCR. Actin was used as an internal control for normalization. We observed relatively high level of endogenous SMO expression in all three mesothelioma cell lines examined, including H28, H290 and REN (Figure 5A). Notably, Cyclopamine treatment significantly suppressed proliferation of these mesothelioma cells in a dose-dependent manner (Figure 5B-D). These

results strongly support that Hh signaling plays essential role in mesothelioma cell proliferation. Figure 5 Analysis of SMO expression and function in mesothelioma cell lines. Tangeritin (A) Western analysis of SMO expression in mesothelioma cell lines. (B-D) MTS proliferation assay of mesothelioma cell lines following SMO inhibitor cyclopamine treatment. Role of Hh activation in mesothelioma Hh signaling plays pivotal roles in development and in cancer. It is implicated in tumorigenesis of multiple human cancers. However, whether Hh signaling plays essential roles in mesothelioma remains elusive. We have analyzed both mRNA and protein expression profiles of mesothelioma tumor samples from 46 patients, and showed that SHH and SMO expression was spreading over a wide range of expression levels (Figure 6). To assess whether Hh signaling activation may impact on the prognosis of mesothelioma patients, we carried out univariant and multivariant COX proportional hazard ratio analysis. Interestingly, we observed that higher SMO expression levels are strongly associated with worse overall survival in malignant pleural mesothelioma after adjusting for age, sex, and histological type (Figures 2, 3A).